Zidovudine-related erythroderma and successful desensitization: a case report. 1996

S Duque, and J de la Puente, and F Rodríguez, and L Fernandez Pellón, and E Maquiera, and J Jerez
Allergy Unit, Hospital Sierrallana, Torrelavega, Spain.

UI MeSH Term Description Entries
D008297 Male Males
D003873 Dermatitis, Exfoliative The widespread involvement of the skin by a scaly, erythematous dermatitis occurring either as a secondary or reactive process to an underlying cutaneous disorder (e.g., atopic dermatitis, psoriasis, etc.), or as a primary or idiopathic disease. It is often associated with the loss of hair and nails, hyperkeratosis of the palms and soles, and pruritus. (From Dorland, 27th ed) Dermatitis Exfoliative,Dermatitis Exfoliative Generalised,Dermatitis Exfoliative Generalized,Erythroderma,Dermatitis Exfoliativa,Dermatitis Exfoliative Generaliseds,Dermatitis Exfoliatives,Erythrodermas,Exfoliative Dermatitides,Exfoliative Dermatitis,Exfoliative Generalised, Dermatitis,Exfoliative Generalized, Dermatitis,Exfoliative, Dermatitis,Exfoliatives, Dermatitis,Generalised, Dermatitis Exfoliative
D003888 Desensitization, Immunologic Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity. Allergen Immunotherapy,Allergy Shots,Hyposensitization Therapy,Immunotherapy, Allergen,Venom Immunotherapy,Immunologic Desensitization,Therapy, Hyposensitization,Allergen Immunotherapies,Allergy Shot,Desensitizations, Immunologic,Hyposensitization Therapies,Immunologic Desensitizations,Immunotherapy, Venom,Shot, Allergy,Venom Immunotherapies
D004306 Dose-Response Relationship, Immunologic A specific immune response elicited by a specific dose of an immunologically active substance or cell in an organism, tissue, or cell. Immunologic Dose-Response Relationship,Relationship, Immunologic Dose-Response,Dose Response Relationship, Immunologic,Dose-Response Relationships, Immunologic,Immunologic Dose Response Relationship,Immunologic Dose-Response Relationships,Relationship, Immunologic Dose Response,Relationships, Immunologic Dose-Response
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U

Related Publications

S Duque, and J de la Puente, and F Rodríguez, and L Fernandez Pellón, and E Maquiera, and J Jerez
January 2014, Journal of investigational allergology & clinical immunology,
S Duque, and J de la Puente, and F Rodríguez, and L Fernandez Pellón, and E Maquiera, and J Jerez
January 2007, American journal of therapeutics,
S Duque, and J de la Puente, and F Rodríguez, and L Fernandez Pellón, and E Maquiera, and J Jerez
January 2008, Journal of cardiac surgery,
S Duque, and J de la Puente, and F Rodríguez, and L Fernandez Pellón, and E Maquiera, and J Jerez
January 2014, The journal of allergy and clinical immunology. In practice,
S Duque, and J de la Puente, and F Rodríguez, and L Fernandez Pellón, and E Maquiera, and J Jerez
September 2018, Therapie,
S Duque, and J de la Puente, and F Rodríguez, and L Fernandez Pellón, and E Maquiera, and J Jerez
October 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners,
S Duque, and J de la Puente, and F Rodríguez, and L Fernandez Pellón, and E Maquiera, and J Jerez
March 2018, Revista medica de Chile,
S Duque, and J de la Puente, and F Rodríguez, and L Fernandez Pellón, and E Maquiera, and J Jerez
January 1990, Acta haematologica,
S Duque, and J de la Puente, and F Rodríguez, and L Fernandez Pellón, and E Maquiera, and J Jerez
September 2010, Transfusion,
S Duque, and J de la Puente, and F Rodríguez, and L Fernandez Pellón, and E Maquiera, and J Jerez
January 2023, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology,
Copied contents to your clipboard!